Detalhe da pesquisa
1.
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors.
Ann Surg
; 272(5): 855-862, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32889867